IP Verse

Pfizer vs. Glaxosmithkline - UPC_CFI_476/2024

The case UPC_CFI_476/2024 was filed by the plaintiff Pfizer against the defendant Glaxosmithkline Biologicals on 14 Aug, 2024.

Case Timeline

14 Aug, 2024
Case Filed
14 Aug, 2024
Counterclaim for Revocation
15 Oct, 2024
Interim Conference
19 Feb, 2025
Oral Procedure
Today Nov 1, 2025
Decision

Case Details

    Case Number:

    UPC_CFI_476/2024

    Patent Number:

    EP4183412

    Filing Date:

    14 Aug, 2024

    Proceeding Type:

    Revocation

    Case Phase:

    Case Closed

    Plaintiffs:

    • Pfizer
    • Pfizer Europe MA Eeig
    • Pfizer Manufacturing Belgium
    • Pfizer Pharma
    • Pfizer Service

    Plaintiff Representative:

    • Gareth Williams

    Defendants:

    • Glaxosmithkline Biologicals

    Defendant Representative:

    • Daniela Kinkeldey

    Judges:

    • Andrea Postiglione
    • Anna-Lena Klein
    • Steen Lyders Wadskov-Hansen

    Court Division:

    First Instance, Central Division - Milan

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

Last updated on: Oct 30, 2025
DateTitle

Notify me when new UPC document is filed

Apr 28, 2025Case Closure Formal Check
Apr 22, 2025Template Order
Apr 22, 2025Outcome Of The Order
Apr 22, 2025Order On Request To Withdraw
Apr 11, 2025Receipt
Apr 10, 2025Receipt
Apr 10, 2025Application For Leave To Withdraw An Action
Apr 10, 2025250410 Gsk Withdrawal Of Applications To Amend
Mar 28, 2025Preliminary Order Claimant To Reply
Mar 27, 2025D45 Uk Order
Mar 27, 2025250327 Gsk Statement In Reply To R.190 Rop Application
Mar 14, 2025Receipt
Mar 14, 2025Preliminary Order Defendant To Reply To Application
Mar 13, 2025Rule 190 Application
Mar 13, 2025Exhibit Pfizer 44
Mar 13, 2025Exhibit Pfizer 43
Mar 13, 2025Exhibit Pfizer 42
Mar 1, 2025Template Order
Mar 1, 2025Summons To The Interim Conference
Mar 1, 2025Hearing Dates
Feb 21, 2025Outcome Of The Order
Feb 21, 2025Extension Reply
Feb 19, 2025Summons To The Oral Hearing
Feb 19, 2025Hearing Dates
Feb 11, 2025250211 Gsk Statement In Reply To R.9 Rop Application
Feb 5, 2025Invitation To Comment On Extension Request
Jan 28, 2025Receipt
Jan 27, 2025Rule 9 Application
Jan 27, 2025Pfizer Exhibit 41
Jan 13, 2025Formal Checks Notification Of Positive Outcome
Jan 13, 2025D44 4
Jan 13, 2025D44 3
Jan 13, 2025D44 2
Jan 13, 2025D44 1
Jan 13, 2025D43
Jan 13, 2025D42
Jan 13, 2025D41
Jan 13, 2025D40
Jan 13, 2025D39
Jan 13, 2025D38
Jan 13, 2025D37
Jan 13, 2025D36
Jan 13, 2025D35
Jan 13, 2025D34
Jan 13, 2025D33(3)
Jan 13, 2025D33(2)
Jan 13, 2025D33(1)
Jan 13, 2025D32
Jan 13, 2025D31
Jan 13, 2025D30
Jan 13, 2025D29
Jan 13, 2025D28
Jan 13, 2025D27
Jan 13, 2025D26
Jan 13, 2025D25
Jan 13, 2025D24
Jan 13, 2025D23
Jan 13, 2025D22
Jan 13, 2025D21
Jan 13, 2025D20
Jan 13, 2025D19
Jan 13, 2025D18(2)
Jan 13, 2025D18(1)
Jan 13, 2025D17(2)
Jan 13, 2025D17(1)
Jan 13, 2025D16
Jan 13, 2025D15
Jan 13, 2025D14
Jan 13, 2025D13
Jan 13, 2025D12
Jan 13, 2025D11
Jan 13, 2025D10
Jan 13, 2025D09(2)
Jan 13, 2025D09(1)
Jan 13, 2025D08
Jan 13, 2025D07
Jan 13, 2025D06
Jan 13, 2025Acknowledgement Of Lodging
Jan 13, 2025250113 Gsk Defence To Revocation
Dec 11, 2024Outcome Of The Order
Dec 11, 2024Order 2Nd Extension
Dec 6, 2024Receipt
Dec 6, 2024241206 Gsk R.9 Request For Further Extension
Dec 3, 2024Template Order
Dec 3, 2024Preliminary Objection Decisionoutcome
Dec 3, 2024Order On Preliminary Objection
Nov 14, 2024Order Time Period Extension
Oct 28, 2024Reply To The Preliminary Objection
Oct 28, 2024Pfizer Exhibit 40 Correspondence Marks Clerk Law And Gowling (Uk)
Oct 28, 2024Pfizer Exhibit 39 Certificates Of Service (Infringement Proceedings)
Oct 28, 2024Pfizer Exhibit 38 Pfizer Response To Reply To Preliminary Objection (Infringement Proceedings)
Oct 28, 2024Pfizer Exhibit 37 Pfizer Preliminary Objection (Infringement Proceedings)
Oct 28, 2024Comment On Preliminary Objection
Oct 17, 2024Panel Appointment
Oct 15, 2024Preliminaryobjection
Oct 15, 2024D05 EP4183412B1
Oct 15, 2024D04 Response To Preliminary Objection
Oct 15, 2024D03 Epo Decision To Grant EP4183412
Oct 15, 2024D02 Receipt
Oct 15, 2024D01 Preliminary Objection (Infringement Action)
Oct 15, 2024241015 Gsk Preliminary Objection
Sep 17, 2024Receipt Belgium Glaxosmithkline Biologicals S.A.
Sep 17, 2024Notification Of Service
Sep 17, 2024Acknowledgement Of Access To Case
Aug 21, 2024Letter For Service
Aug 20, 2024Epouploaddocumentsworkflow
Aug 19, 2024Panel Appointment
Aug 19, 2024Document From Epo
Aug 16, 2024Formal Checks Notification Of Positive Outcome
Aug 16, 2024Epo Request For Case Pending
Aug 16, 2024Acknowledgement Of Lodging
Aug 14, 2024Statement For Revocation
Aug 14, 2024Exhibit Ww 9
Aug 14, 2024Exhibit Ww 8
Aug 14, 2024Exhibit Ww 7
Aug 14, 2024Exhibit Ww 6
Aug 14, 2024Exhibit Ww 5
Aug 14, 2024Exhibit Ww 4
Aug 14, 2024Exhibit Ww 3
Aug 14, 2024Exhibit Ww 2
Aug 14, 2024Exhibit Ww 10
Aug 14, 2024Exhibit Ww 1
Aug 14, 2024Exhibit Pfizer 9
Aug 14, 2024Exhibit Pfizer 9
Aug 14, 2024Exhibit Pfizer 8
Aug 14, 2024Exhibit Pfizer 8
Aug 14, 2024Exhibit Pfizer 7
Aug 14, 2024Exhibit Pfizer 7
Aug 14, 2024Exhibit Pfizer 6
Aug 14, 2024Exhibit Pfizer 5
Aug 14, 2024Exhibit Pfizer 4
Aug 14, 2024Exhibit Pfizer 36
Aug 14, 2024Exhibit Pfizer 35
Aug 14, 2024Exhibit Pfizer 34
Aug 14, 2024Exhibit Pfizer 33
Aug 14, 2024Exhibit Pfizer 32
Aug 14, 2024Exhibit Pfizer 31
Aug 14, 2024Exhibit Pfizer 30
Aug 14, 2024Exhibit Pfizer 3
Aug 14, 2024Exhibit Pfizer 29
Aug 14, 2024Exhibit Pfizer 28
Aug 14, 2024Exhibit Pfizer 27
Aug 14, 2024Exhibit Pfizer 26
Aug 14, 2024Exhibit Pfizer 25
Aug 14, 2024Exhibit Pfizer 24
Aug 14, 2024Exhibit Pfizer 23
Aug 14, 2024Exhibit Pfizer 22
Aug 14, 2024Exhibit Pfizer 21
Aug 14, 2024Exhibit Pfizer 20
Aug 14, 2024Exhibit Pfizer 2
Aug 14, 2024Exhibit Pfizer 2
Aug 14, 2024Exhibit Pfizer 19
Aug 14, 2024Exhibit Pfizer 18
Aug 14, 2024Exhibit Pfizer 17
Aug 14, 2024Exhibit Pfizer 16
Aug 14, 2024Exhibit Pfizer 15
Aug 14, 2024Exhibit Pfizer 15
Aug 14, 2024Exhibit Pfizer 14
Aug 14, 2024Exhibit Pfizer 13
Aug 14, 2024Exhibit Pfizer 12
Aug 14, 2024Exhibit Pfizer 11
Aug 14, 2024Exhibit Pfizer 10
Aug 14, 2024Exhibit Pfizer 1
Aug 14, 2024Exhibit Pfizer 1

More cases involving EP4183412B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
UPC_CFI_687/2024Nov 15, 2024Laboratorios Pfizer, Pfizer, Pfizer AB, Pfizer Austria, Pfizer LuxembourgGlaxosmithkline
CC_60908/2024Nov 14, 2024Laboratorios Pfizer, Pfizer, Pfizer Austria, Pfizer LuxembourgGlaxosmithkline
ACT_45928/2024Aug 14, 2024Pfizer, Pfizer Europe MA Eeig, Pfizer Manufacturing Belgium, Pfizer Pharma, Pfizer ServiceGlaxosmithkline

More cases involving Pfizer

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_29242/2025Jul 3, 2025Pfizer, Pfizer AB, Pfizer Manufacturing Belgium -
UPC_CFI_485/2025Jun 19, 2025Pfizer, Pfizer AB, Pfizer Manufacturing BelgiumThe Scripps Research Institute
APP_29243/2025Jun 18, 2025Pfizer, Pfizer AB, Pfizer Manufacturing BelgiumBiontech, Biontech Europe, Biontech Innovative Manufacturing Services, Biontech Manufacturing, Biontech Manufacturing Marburg, Promosome

More cases involving Glaxosmithkline

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_33242/2025Jul 21, 2025Glaxosmithkline -
APP_33256/2025Jul 21, 2025Glaxosmithkline -
APP_33285/2025Jul 21, 2025Glaxosmithkline -